| abstract |
The present invention relates to novel compounds of formula (1a) or formula (1b): (1a), or (1b) and salts thereof, wherein S, T, W, Z, AA 1 , AA 2 , AA 3 , AA 4 , AA 5 , AA 6 , AA 7 , AA 8 , AA 9 , AA 10 , AA 11 , AA 12 , AA 13 , AA 14 , AA 15 , A 16 , AA 17 , AA 18 , AA 19 , AA 20 , AA 21 , AA 22 , S a , T a , W a , X a , Y a , Z a , AA 1a , AA 2a , AA 3a , AA 4a , AA 5a , AA 6a , AA 7a , AA 8a , AA 9a , AA 10a , AA 11a , AA 12a , AA 13a , AA 14a , AA 15a , A 16a , R, R 1 and R 2 is defined herein, and its use in treating, preventing, ameliorating, modulating or reducing the risk of disorders associated with glucagon-like peptide (GLP) receptors. |